Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 354.00
-10.60 (-2.91%)
At close: Jan 20, 2026
Medicamen Biotech Employees
Medicamen Biotech had 376 employees as of March 31, 2025. The number of employees decreased by 2 or -0.53% compared to the previous year.
Employees
376
Change (1Y)
-2
Growth (1Y)
-0.53%
Revenue / Employee
4.52M INR
Profits / Employee
240.77K INR
Market Cap
4.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 376 | -2 | -0.53% |
| Mar 31, 2024 | 378 | -10 | -2.58% |
| Mar 31, 2023 | 388 | 31 | 8.68% |
| Mar 31, 2022 | 357 | 68 | 23.53% |
| Mar 31, 2021 | 289 | 25 | 9.47% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Albert David | 1,805 |
| Kopran | 1,024 |
| Jenburkt Pharmaceuticals | 779 |
| ZIM Laboratories | 577 |
| Kerala Ayurveda | 367 |
| Everest Organics | 355 |
| Medico Remedies | 213 |
| Kilitch Drugs (India) | 187 |
Medicamen Biotech News
- 8 months ago - Medicamen Biotech secures USFDA nod for Bortezomib injection, marks its first ANDA approval - Business Upturn
- 11 months ago - Medicamen Biotech expands into South Africa after EU approval, eyes $4 billion pharmaceutical market - Business Upturn
- 1 year ago - Medicamen Biotech shares jump 3.50% after signing long-term manufacturing deal for US and Europe - Business Upturn
- 1 year ago - Medicamen Biotech secures 10-year manufacturing and supply deal with leading US pharma distributor - Business Upturn
- 1 year ago - Medicamen Biotech shares surge nearly 15% - Business Upturn